For immediate release

23 May 2017

Nyota Minerals Limited

('Nyota' or 'the Company')

Board Changes

The Board of Nyota announces that the Company has today appointed James Normand as a non-executive director of the Company with effect from 31 May 2017.

Mr Normand qualified as a Chartered Accountant in 1978, having trained with Spicer and Pegler (now part of Deloitte).  Following a secondment (from 1985 to 1987) to 3i plc, Mr Normand specialised for the next 15 years in the provision of advice to management buy-out and buy-in teams and on corporate acquisitions, disposals and capital raisings.  Since 2002, Mr Normand has filled management and finance officer roles for a number of different commercial and charitable organisations.  Most recently, from 2009 to 2016, he was Finance Director of Pathfinder Minerals Plc, an AIM-traded minerals company.

In an unremunerated extra-curricular capacity, Mr Normand is active in the governance of the Church of England, being Chair of the London Diocesan Synod's House of Laity and Chair of the Finance and Remuneration Committees of the Bishop of London's Council.

The following information is disclosed pursuant to paragraph (g) of Schedule Two of the AIM Rules for Companies.

Mr James Patrick Normand, aged 63, has held the following directorships and / or partnerships in the past 5 years:

As at the date of this announcement, Mr Normand does not have any interest in any ordinary shares of the Company. There  is  no  further  information  to  be  disclosed  in  relation  to  Mr  Normand  pursuant to paragraph (g) of Schedule Two of the AIM Rules for Companies.

Mr Jonathan Morley-Kirk has, as previously announced on 3 May 2017, resigned from the Board of the Company with effect from 31 May 2017 and all outstanding fees due to Mr Morley-Kirk are to be paid in new ordinary shares at the same issue price as the placing announced on 3 May 2017 subject to approval by the shareholders at an extraordinary general meeting of the Company.

For further information please visit www.nyotaminerals.com or contact:

This announcement contains inside information for the purposes of Article 7 of EU Regulation 956/2014.

**ENDS**